Therapeutic drug monitoring for invasive mould infections and disease: pharmacokinetic and pharmacodynamic considerations.
about
New pharmacological opportunities for the treatment of invasive mould diseases.Exposure-Response Relationships for Isavuconazole in Patients with Invasive Aspergillosis and Other Filamentous Fungi.Pharmacogenomics of triazole antifungal agents: implications for safety, tolerability and efficacy.Pharmacokinetic Modeling of Voriconazole To Develop an Alternative Dosing Regimen in Children.Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO).
P2860
Therapeutic drug monitoring for invasive mould infections and disease: pharmacokinetic and pharmacodynamic considerations.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Therapeutic drug monitoring fo ...... harmacodynamic considerations.
@en
type
label
Therapeutic drug monitoring fo ...... harmacodynamic considerations.
@en
prefLabel
Therapeutic drug monitoring fo ...... harmacodynamic considerations.
@en
P2860
P356
P1476
Therapeutic drug monitoring fo ...... harmacodynamic considerations.
@en
P2860
P304
P356
10.1093/JAC/DKX029
P407
P433
P577
2017-03-01T00:00:00Z